fertilizer
Commented by Matthias Schomber on June 5th, 2026 | 07:00 CEST
Global Food Security Meets Agritech Innovation: New Developments from Bayer, Nutrien, and MustGrow Biologics
Created and published on behalf of MustGrow Biologics Corp.
Global hunger has been rising dramatically for years and already affects over 750 million people worldwide. Geopolitical conflicts such as the war in Ukraine, the pandemic's aftermath, and intensifying droughts driven by the climate crisis are exposing the extreme vulnerability of our global food supply. To permanently reverse this dangerous trend, development organizations like Bread for the World are calling for a profound, ecological transformation away from pure agribusiness toward sustainable, resilient systems. In this context, agribusiness conglomerates and innovative pioneer companies are under significant pressure to deliver effective solutions quickly. But how are established industry leaders responding to these historic challenges, and what role do innovative organic approaches play in this future market worth hundreds of billions? A look at current market trends reveals where the momentum for a new era in agriculture is building.
Read
Commented by Jens Castner on June 3rd, 2026 | 07:10 CEST
HOT MUSTARD FOR SWEET FRUITS: HOW MUSTGROW BIOLOGICS IS SPARKING A REVOLUTION IN AGRICULTURE
Created and published on behalf of MustGrow Biologics Corp.
From summer strawberry stands to the stock market: as chemical pesticides and fertilizers face increasing regulatory pressure worldwide, demand for biological crop protection solutions is accelerating. Positioned at the forefront of this transition is MustGrow Biologics Corp. Leveraging the natural defence mechanisms of the mustard plant and supported by strategic industry partnerships, including Bayer, the company aims to scale its technology for global agricultural markets.
Read
Commented by Armin Schulz on May 28th, 2026 | 08:30 CEST
Bayer, MustGrow Biologics, K+S: The Secret Formula for Success Behind the Biological Fertilizer Revolution
Created and published on behalf of MustGrow Biologics Corp.
The global fertilizer industry is undergoing its most significant structural transformation in generations. A growing global population, technological breakthroughs in biological agricultural solutions, and policy shifts toward more sustainable agriculture are driving this growth sector. The need for more efficient nutrient use is giving rise to a dynamic market with fresh revenue potential. Companies that pursue the right strategies now are positioning themselves for the coming decade. Three players from different worlds embody this development in their own way: Bayer, MustGrow Biologics, and K+S.
Read
Commented by Nico Popp on May 20th, 2026 | 08:30 CEST
Disruption in the Agricultural Sector: Why Corteva and Deere & Company Are Keeping an Eye on MustGrow Biologics
Created and published on behalf of MustGrow Biologics Corp.
High energy prices, soil degradation, and consumer preference for organic products—the growing pressure on traditional agricultural chemicals poses an existential challenge to established market leaders. Those who do not embrace biological alternatives now risk falling behind due to growing regulatory requirements and increasing resistance. Driven by historically high energy prices, which make the production of conventional fertilizers more expensive, agricultural businesses are facing cost pressures. This economic predicament is becoming a catalyst for innovation: major corporations are investing billions in digital solutions and biologically active ingredients. We shed light on this trend and introduce exciting companies.
Read
Commented by Matthias Schomber on May 14th, 2026 | 07:55 CEST
Bayer and BASF on a Performance High — and MustGrow Biologics as a Secret Weapon Against World Hunger!
Created and published on behalf of MustGrow Biologics Corp.
The world's population is growing inexorably, and with it the demand for efficient—but above all sustainable—solutions in agriculture. While the German heavyweights Bayer and BASF have recently impressed markets with strong performance and further cemented their dominant positions, a smaller player is preparing to emerge from the slipstream of the industry giants and join the major leagues. Hardly anyone is likely to have this stock on their radar yet, but it would be worth at least adding it to the watchlist. MustGrow Biologics may have endured a difficult stretch on the stock market, but recent strategic decisions and regulatory successes suggest that the company could be delivering the right answers to pressing global food security challenges at exactly the right time. The market currently appears to be bottoming out, which could mark an attractive entry point for risk-tolerant investors before the biological agriculture trend gains further momentum. In this report, we examine the latest developments at these three companies in the battle for the farmland of the future.
Read
Commented by Fabian Lorenz on May 13th, 2026 | 07:30 CEST
Takeover at Bayer! Shock at Rheinmetall! Opportunity for MustGrow Stock!
Created and published on behalf of MustGrow Biologics Corp.
The blockade of the Strait of Hormuz is turning into a stress test for global food security. Supply chains across the fertilizer industry are coming under pressure — and this could create a significant opportunity for MustGrow Biologics. The company's organic biological fertilizer (biofertilizer) is being approved in an increasing number of US states. And in the field of biological crop protection, they are collaborating with Bayer. Meanwhile, Rheinmetall is grappling with disappointed market expectations. Revenues at the defence contractor are simply not growing fast enough, although the company continues to modernize its product portfolio.
Read
Commented by André Will-Laudien on May 7th, 2026 | 08:25 CEST
Moving Ahead with Strong Concepts and Easing Tensions in the Middle East! MustGrow, K+S, Evotec, and Novo Nordisk in Focus
Created and published on behalf of MustGrow Biologics Corp.
What a headline: An agreement between the US and Iran – markets up 2% in just one minute! It can happen that fast. For investors, this is welcome news, as a de-escalation in the Iran conflict would significantly ease global supply chains and reduce pressure on critical transport routes. In particular, the Strait of Hormuz would lose some of its significance as a geopolitical risk factor, potentially stabilizing global flows of goods and energy. Easing tensions are also likely to lower transport costs again, shorten delivery times, and dampen price volatility. For companies in the food, healthcare, and agricultural technology sectors, this creates greater planning certainty and new growth opportunities. MustGrow Biologics and K+S could benefit from more stable agricultural markets, while Evotec and Novo Nordisk may gain additional tailwinds in a calmer healthcare environment. Investors are increasingly turning to stocks that promise sustainable growth and reliable returns in a more stable market setting. The key question now: will volatility finally decline as well?
Read
Commented by Armin Schulz on May 5th, 2026 | 07:10 CEST
How to Capitalize on Two of the Greatest Crises of Our Time – Thanks to Novo Nordisk, MustGrow Biologics, and Bayer
Created and published on behalf of MustGrow Biologics Corp.
While the world battles an obesity epidemic that has turned Novo Nordisk into a cash cow, a potential conflict with Iran threatens to tear apart global agricultural supply chains. More than 2.5 billion people are overweight, while war-induced fertilizer shortages could destroy crops. Two seemingly contradictory crises collide—pharmaceutical solutions for obesity on one side, biological crop protection products against famine on the other. It is precisely in this tension that three companies, each pursuing different approaches, are operating: Novo Nordisk, MustGrow Biologics, and Bayer.
Read
Commented by Nico Popp on April 30th, 2026 | 07:30 CEST
Food Crisis on the Horizon? Nutrien and Nestlé on Edge, MustGrow Biologics Offers Solutions
Created and published on behalf of MustGrow Biologics Corp.
The agricultural sector is currently experiencing an unprecedented crisis, triggered by pervasive geopolitical tensions and the Strait of Hormuz blockade. The latter development, in particular, has exposed the Achilles' heel of modern agriculture: the extreme dependence on fossil fuels for fertilizer production and the fragility of global just-in-time supply chains. Since about 20% of the world's crude oil and liquefied natural gas (LNG) flows through this strait, the blockade not only raises energy costs but also directly threatens nitrogen fertilizer production, for which natural gas is the primary cost driver. If fertilizer becomes more expensive, fields could lie fallow, leading to a decline in food production. This could even lead to hunger, particularly in poorer regions of the world. Fertilizer must be applied to fields in a timely manner to be effective. In this environment, established giants like Nutrien and Nestlé must radically optimize their business models, while players such as MustGrow Biologics are gaining importance as drivers of innovation.
Read
Commented by Fabian Lorenz on April 24th, 2026 | 07:05 CEST
SHOCK AND OPPORTUNITY: Nel ASA, K+S, and Bayer Partner MustGrow - Which Stock Stands Out?
When will MustGrow Biologics finally break out? In reality, it may only be a matter of time. The Canadians replace conventional fertilizers with mustard-based solutions. In the United States, regulatory approvals have already been obtained. There alone, the revenue potential is estimated at USD 100 million. The company is currently valued at only around CAD 35 million. To unlock global potential, it has brought in partners including Bayer. As a result, the stock appears significantly undervalued. For K+S, valuation is becoming the issue. Despite surprisingly strong numbers, analysts see no further upside potential. Nel ASA has also released its results. However, the hydrogen specialist appears to have rather shocked its shareholders. The development is concerning, and the share price drop of over 10% may only be the beginning of further weakness.
Read